Valeant Pharmaceuticals International Inc. is ending its relationship with a mail-order pharmacy helped sell one of several older drugs it has acquired and raised prices on.
The pharmacy, Direct Success Inc., was used by Valeant to distribute the antidepressant Wellbutrin XL. Valeant, in a statement, confirmed the end of the relationship, although it said the pharmacy only handled about 5 percent of the sales of the product last year. The change was first noted by David Maris, an analyst with Wells Fargo & Co.
